Search details
1.
Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase.
Blood Adv
; 4(20): 5246-5256, 2020 10 27.
Article
in English
| MEDLINE | ID: mdl-33104796
Results
1 -
1
de 1
1
Next >
>>